Literature DB >> 33210530

High-Throughput Immunochemical Method to Assess the 2-Heptyl-4-quinolone Quorum Sensing Molecule as a Potential Biomarker of Pseudomonas aeruginosa Infections.

Enrique J Montagut1,2, Lluisa Vilaplana1,2, M Teresa Martin-Gomez3,4, M Pilar Marco1,2.   

Abstract

Bacterial quorum sensing (QS) is being contemplated as a promising target for developing innovative diagnostic and therapeutic strategies. Here we report for the first time the development of antibodies against 2-heptyl-4-quinolone (HHQ), a signaling molecule from the pqs QS system of Pseudomonas aeruginosa, involved in the production of important virulent factors and biofilm formation. The antibodies produced were used to develop an immunochemical diagnostic approach to assess the potential of this molecule as a biomarker of P. aeruginosa infection. The ELISA developed is able to reach a detectability in the low nM range (IC50 = 4.59 ± 0.29 nM and LOD = 0.34 ± 0.13 nM), even in complex biological samples such as Müeller Hinton (MH) culture media. The ELISA developed is robust and reproducible and has been found to be specific to HHQ, with little interference from other related alkylquinolones from the pqs QS system. The ELISA has been used to analyze the HHQ production kinetics of P. aeruginosa clinical isolates grown in MH media, pointing to its potential as a biomarker of infection and at the possibility to use the technology developed to obtain additional information about the disease stage.

Entities:  

Keywords:  2-heptyl-4-quinolone; ELISA; HHQ; Pseudomonas aeruginosa; antibodies; bacterial quorum sensing

Mesh:

Substances:

Year:  2020        PMID: 33210530     DOI: 10.1021/acsinfecdis.0c00604

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  7 in total

Review 1.  Biological and clinical significance of quorum sensing alkylquinolones: current analytical and bioanalytical methods for their quantification.

Authors:  Enrique J Montagut; M Pilar Marco
Journal:  Anal Bioanal Chem       Date:  2021-05-07       Impact factor: 4.142

2.  Diagnosis and Stratification of Pseudomonas aeruginosa Infected Patients by Immunochemical Quantitative Determination of Pyocyanin From Clinical Bacterial Isolates.

Authors:  Barbara Rodriguez-Urretavizcaya; Nuria Pascual; Carme Pastells; Maria Teresa Martin-Gomez; Lluïsa Vilaplana; Maria-Pilar Marco
Journal:  Front Cell Infect Microbiol       Date:  2021-12-14       Impact factor: 5.293

3.  Direct Quantitative Immunochemical Analysis of Autoinducer Peptide IV for Diagnosing and Stratifying Staphylococcus aureus Infections.

Authors:  Enrique-J Montagut; Gerardo Acosta; Fernando Albericio; Miriam Royo; Gerard Godoy-Tena; Alicia Lacoma; Cristina Prat; Juan-Pablo Salvador; María-Pilar Marco
Journal:  ACS Infect Dis       Date:  2022-02-17       Impact factor: 5.084

4.  Design and Synthesis of New Pyrimidine-Quinolone Hybrids as Novel hLDHA Inhibitors.

Authors:  Iván Díaz; Sofia Salido; Manuel Nogueras; Justo Cobo
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-24

5.  Label-Free Electrochemical Aptasensor for the Detection of the 3-O-C12-HSL Quorum-Sensing Molecule in Pseudomonas aeruginosa.

Authors:  Denisa Capatina; Teodora Lupoi; Bogdan Feier; Adrian Blidar; Oana Hosu; Mihaela Tertis; Diana Olah; Cecilia Cristea; Radu Oprean
Journal:  Biosensors (Basel)       Date:  2022-06-22

6.  An Immunocolorimetric Sensing System for Highly Sensitive and High-Throughput Detection of BNP with Carbon-Gold Nanocomposites Amplification.

Authors:  Xin Liu; Ying Gan; Fengheng Li; Yong Qiu; Yuxiang Pan; Hao Wan; Ping Wang
Journal:  Biosensors (Basel)       Date:  2022-08-09

7.  An Immunochemical Approach to Detect the Quorum Sensing-Regulated Virulence Factor 2-Heptyl-4-Quinoline N-Oxide (HQNO) Produced by Pseudomonas aeruginosa Clinical Isolates.

Authors:  Enrique J Montagut; Juan Raya; M-Teresa Martin-Gomez; Lluïsa Vilaplana; Barbara Rodriguez-Urretavizcaya; M-Pilar Marco
Journal:  Microbiol Spectr       Date:  2022-07-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.